This year’s European Laboratory Research and Innovation Group (ELRIG) Drug Discovery conference is being hosted in Liverpool, and will feature a number of leading researchers in the area of drug development, including Professor Sir Munir Pirmohamed.
The flagship Drug Discovery event, 13-14 October 2016 at the Arena & Convention Centre Liverpool, is the UK’s largest free to attend event of its kind. It will bring together industry leaders from across the pharma, biotech, academia and vendor communities to discuss future opportunities for novel therapeutic discovery.
Leading clinical experts
Professor Sir Munir Pirmohamed, one of the country’s leading clinical experts, based at University of Liverpool’s Institute of Translational Medicine, will be Plenary Speaker at this event.
Professor Pirmohamed will speak on Drug Safety in Drug Development.
The six main sessions will cover: Innovations in Chemistry; Oncology & Immunology; Innovations in Predictive & Translational Models; Assay Development, Screening & Emerging Technologies; Coming Closer to the Patient – Cells and Genes in Therapy and Diagnostics; and Target Identification & Validation.
Disrupting previous thinking
The conference will also explore innovative technologies and approaches that can be used to overcome drug development challenges.
Another addition to the conference this year is a series of Core Technologies Workshops & Vendor Tutorials. These will provide a more informal, interactive environment for attendees to discuss key issues and future directions in workshops coordinated by leaders in the fields.
Dr Peter Simpson, director of N8 Research Partnership, which is partnering with ELRIG, and who co-chaired last year’s Drug Discovery conference, said: “This event will be a superb opportunity to hear about high quality science, from leading thinkers and innovators as they challenge and disrupt previous thinking.
“As Director of N8, I’m absolutely convinced that bringing the whole community of academia, SMEs and major companies together truly fosters innovation and collaboration. It is great that this event is returning to the North, a region where Health Innovation is highlighted as a major economic capability. Great advancement will come from quality research insights, informal discussions, and networking, to the benefit the drug discovery and life science communities.”
For more information about the event please visit: http://elrig.org/drug-discovery-2016-registration/